AG00HRMT

127-79-7 | Benzenesulfonamide, 4-​amino-​N-​(4-​methyl-​2-​pyrimidinyl)​-

AG00HRMT

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	127-79-7
Catalog Number	AG00HRMT(AGN-PC-07A26W)
Chemical Name	Benzenesulfonamide, 4-​amino-​N-​(4-​methyl-​2-​pyrimidinyl)​-
EC Number	204-866-2
IUPAC Name	4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide
InChI	InChI=1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)
InChI Key	QPPBRPIAZZHUNT-UHFFFAOYSA-N
MDL Number	MFCD00023212
Molecular Formula	C11H12N4O2S
Molecular Weight	264.3036
SMILES	S(=O)(=O)(Nc1nc(C)ccn1)c1ccc(cc1)N
UNII	UR1SAB295F
Synonyms	Mebacid, Methylsulfadiazine, Sulfamerazine, Trimetox, sulfamerazine, 127-79-7, Sulphamerazine, Sulfamethyldiazine, Sulfamerazin, Cremomerazine, Methylsulfazine, Sulfameradine, Mebacid, Metilsulfadiazin, Methylpyrimal, Metilsulfazin, Sulfamerazina, Sulfamerazinum, Kelamerazine, Percoccide, Pyralcid, Septacil, Septosyl, Solumedin, Sumedine, Mesulfa, Romezin, Veta-Merazine, 2-Sulfa-4-methylpyrimidine, Debenal-M, Pirimal-M, Pyrimal M, Methylsulfazin, 4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide, Solfamerazina, N-(4-Methyl-2-pyrimidyl)sulfanilamide, Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-, 2-(Sulfanilamido)-4-methylpyrimidine, 2-(4-Aminobenzenesulfonamido)-4-methylpyrimidine, 2643-RP, RP 2632, Solfamerazina [DCIT], Sulfamerazinum [INN-Latin], N1-(4-Methyl-2-pyrimidinyl)sulfanilamide, Sulfamerazina [INN-Spanish], (p-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin, A-310, 2-Sulfanilamido-4-methylpyrimidine, UNII-UR1SAB295F, 4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide, NSC 27259, C11H12N4O2S, 4-Amino-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide, CHEBI:102130, 2632 R. P., N(1)-(4-Methyl-2-pyrimidinyl)sulfanilamide, EINECS 204-866-2, MFCD00023212, N(sup 1)-(4-Methyl-2-pyrimidinyl)sulfanilamide, BRN 0249133, UR1SAB295F, AI3-08026, MLS000551747, 4-amino-N-(4-methylpyrimidin-2-yl)benzene-1-sulfonamide, (p-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin [German], Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)-, 2-(p-Aminobenzolsulfonamido)-4-methylpyrimidine, QPPBRPIAZZHUNT-UHFFFAOYSA-N, Sulfanilamide, N(sup 1)-(4-methyl-2-pyrimidinyl)-, NCGC00016386-01, CAS-127-79-7, SMR000145672, DSSTox_CID_3612, DSSTox_RID_77109, DSSTox_GSID_23612, 4-Amino-N-(4-methyl-pyrimidin-2-yl)-benzenesulfonamide, Sulfamerazine (INN), Sulfamerazine [USAN:INN:BAN], SR-01000684857, [(4-aminophenyl)sulfonyl](4-methylpyrimidin-2-yl)amine, Susfamerazine, Sulfamerazine [USP:INN:BAN], Prestwick_17, Spectrum_000003, Opera_ID_988, Prestwick0_000694, Prestwick1_000694, Prestwick2_000694, Prestwick3_000694, Spectrum2_001320, Spectrum3_001363, Spectrum4_000343, Spectrum5_001413, 2(p-Aminobenzolsulfonamido)-4-methylpyrimidin, CHEMBL438, Epitope ID:122236, N(sup1)-(4-Methyl-2-pyrimidinyl)sulfanilamide, AC1L1K3Q, AC1Q2NY3, AC1Q2P0R, SCHEMBL33999, BSPBio_000847, BSPBio_002886, KBioGR_000745, KBioSS_000343, 5-25-10-00167 (Beilstein Handbook Reference), MLS001201765, DivK1c_000563, SPECTRUM1500547, SPBio_001419, SPBio_002768, BPBio1_000933, DTXSID0023612, HMS501M05, KBio1_000563, KBio2_000343, KBio2_002911, KBio2_005479, KBio3_002106, ZINC57501, NINDS_000563, 4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide (9CI), HMS1570K09, HMS1921A15, HMS2092I17, HMS2097K09, HMS2234D16, HMS3374K04, HMS3652I03, HMS3714K09, Pharmakon1600-01500547, ALBB-025702, HY-B0512, KS-00000Z2J, NSC27259, Tox21_110411, BBL003544, CCG-39258, NSC-27259, NSC757325, RP2632, s3132, SBB057970, STK520614, AKOS005143010, Tox21_110411_1, CS-2720, DB01581, KS-5323, MCULE-7699685177, NSC-757325, IDI1_000563, NCGC00016386-02, NCGC00016386-03, NCGC00016386-06, NCGC00094787-01, NCGC00094787-02, AK390512, AN-23008, H548, N'-(4-Methyl-2-pyrimidyl) sulfanilamide, SULFAMERAZINE (TRISULFAPYRIMIDINES), SBI-0051521.P003, 2632 R. P, 2632 R.P., LS-147821, Sulfamerazine, ReagentPlus(R), >=99.0%, AB00052096, FT-0631745, FT-0645132, R1483, ST45028776, SW196334-3, Sulfamerazine, Vetec(TM) reagent grade, 98%, 2-(p-Aminobenzosulfonamido)-4-methylpyrimidine, D02435, AB00052096-13, AB00052096_15, AB00052096_16, A805747, Sulfamerazine, VETRANAL(TM), analytical standard, Q-201761, SR-01000684857-2, SR-01000684857-4, 4-azanyl-N-(4-methylpyrimidin-2-yl)benzenesulfonamide, BRD-K93524252-001-05-6, BRD-K93524252-001-15-5, I14-86083, Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)- (8CI), F2190-0484, Sulfamerazine, European Pharmacopoeia (EP) Reference Standard, Sulfamerazine, United States Pharmacopeia (USP) Reference Standard, Sulfamerazine, Pharmaceutical Secondary Standard; Certified Reference Material, Solumedine, Methylsulfadiazine, Trimetox, Sulfonamide Duplex, Mixture Name, Sulfonamides Duplex, D0H1GJ, component of Sulfonamide Duplex, Sulfonamide Duplex (Salt/Mix), Sulfamerazine [USAN:BAN:INN], CID5325, C11-H12-N4-O2-S, CS-T-42777, N1-(4-methyl-2-pyrimidyl)sulfanilamide, N1-(4-Methylpyrimidin-2-yl)sulfanilamide, B2037, D013416, Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)-(8CI), 2-[(2R,6S)-2,6-Dimethylmorpholin-4-yl]pyridin-3-amine,

Complexity	360
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	264.068g/mol
Formal Charge	0
Heavy Atom Count	18
Hydrogen Bond Acceptor Count	6
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	264.303g/mol
Monoisotopic Mass	264.068g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	106A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	0.1

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number